Innate Pharma S.A. (IPHA) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 46.69M | 64.98M | 85.74M | 111.59M | 148.01M | 144.46M | 139.83M | 171.8M | 138.26M | 129.69M | 173.33M | 163.69M |
| Cash & Short-Term Investments | 34.3M | 60.03M | 80.77M | 91.8M | 92.46M | 88.89M | 101.48M | 123.35M | 119.84M | 119.32M | 151.64M | 147.74M |
| Cash Only | 28.08M | 53.7M | 66.4M | 69.99M | 70.61M | 71.41M | 84.22M | 102.95M | 103.76M | 103.98M | 136.79M | 131.54M |
| Short-Term Investments | 6.22M | 6.32M | 14.37M | 21.81M | 21.85M | 17.48M | 17.26M | 20.4M | 16.08M | 15.34M | 14.85M | 16.2M |
| Accounts Receivable | 12.39M | 363K | 1.64M | 393K | 46.49M | 2.93M | 3.14M | 41.83M | 1.66M | 3.6M | 11.33M | 2.6M |
| Days Sales Outstanding | -280.79 | 18.83 | 336.57 | 173.27 | 136.19 | 7.84 | 246.94 | 48.08 | 85.91 | 73.07 | 23.54 | 6.73 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.28M | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | 64.38 | - |
| Other Current Assets | 0 | 2.44M | 0 | 13.44M | 0 | 49.3M | 27.88M | 0 | 11.81M | 0 | 4.4M | 4.04M |
| Total Non-Current Assets | 16M | 27.96M | 25.32M | 39.9M | 27.18M | 54.59M | 68.03M | 108.63M | 129.24M | 136.53M | 134.09M | 169.38M |
| Property, Plant & Equipment | 4.35M | 4.96M | 5.13M | 5.75M | 6.32M | 7.26M | 8.54M | 9.56M | 10.17M | 10.89M | 11.69M | 12.43M |
| Fixed Asset Turnover | -0.45x | 0.96x | 0.05x | 2.05x | 2.44x | 4.47x | 0.92x | 4.18x | 0.27x | 0.83x | 2.24x | 3.05x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | -41M | 0 | 2K | 0 | 1K | 0 |
| Intangible Assets | 0 | 0 | 0 | 119K | 416K | 903K | 42.55M | 43.25M | 44.19M | 45.19M | 46.29M | 95.22M |
| Long-Term Investments | 10.7M | 10.39M | 10.28M | 10.35M | 9.8M | 35.79M | 35.12M | 34.81M | 39.88M | 40.08M | 38.93M | 36.87M |
| Other Non-Current Assets | 946.6K | 12.61M | 9.9M | 14.56M | 1.64M | 965K | 14.25M | 13.24M | 29.97M | 34.96M | 30.09M | 23.59M |
| Total Assets | 62.69M | 92.94M | 111.06M | 151.5M | 175.19M | 199.05M | 207.86M | 280.43M | 267.5M | 266.22M | 307.42M | 333.07M |
| Asset Turnover | -0.03x | 0.05x | 0.00x | 0.08x | 0.09x | 0.17x | 0.03x | 0.15x | 0.01x | 0.03x | 0.08x | 0.10x |
| Asset Growth % | -43.55% | -38.65% | -36.61% | -23.89% | -15.72% | -29.02% | -22.29% | 5.34% | -12.99% | -20.07% | -23.4% | -5.53% |
| Total Current Liabilities | 36.63M | 29.43M | 32.98M | 38.22M | 39.64M | 37.67M | 41.34M | 73.56M | 79.89M | 42.62M | 46.69M | 82.34M |
| Accounts Payable | 15.04M | 4.55M | 7.92M | 8.75M | 8.56M | 9.87M | 13.66M | 12.92M | 14.73M | 11.18M | 20.73M | 20.11M |
| Days Payables Outstanding | - | 27.74 | -26.16 | 27.17 | 34.22 | 68.25 | 90.82 | 101.11 | 91.66 | 137.31 | 400.56 | 69.6 |
| Short-Term Debt | 8.8M | 8.47M | 8.44M | 8.51M | 8.45M | 5.33M | 1.26M | 30.85M | 29.94M | 2.02M | 1.36M | 2.04M |
| Deferred Revenue (Current) | 2.82M | 0 | 616K | 0 | 5.87M | 5.05M | 6.56M | 9.09M | 12.5M | 10.46M | 12.51M | 41.58M |
| Other Current Liabilities | 9.98M | 15.94M | 7.65M | 20.54M | 7.82M | 17.41M | 19.02M | 20.69M | 21.91M | 18.95M | 22.61M | 18.62M |
| Current Ratio | 1.27x | 2.21x | 2.60x | 2.92x | 3.73x | 3.84x | 3.38x | 2.34x | 1.73x | 3.04x | 3.71x | 1.99x |
| Quick Ratio | 1.27x | 2.21x | 2.60x | 2.92x | 3.73x | 3.84x | 3.38x | 2.34x | 1.73x | 3.04x | 3.64x | 1.99x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | -312.64 | - |
| Total Non-Current Liabilities | 47.75M | 58.37M | 69.24M | 84.48M | 83.65M | 103.52M | 112.37M | 90.54M | 80.17M | 90.04M | 104.75M | 42.96M |
| Long-Term Debt | 13.77M | 17.94M | 22.18M | 26.41M | 30.61M | 35.32M | 38.93M | 12.52M | 11.49M | 14.48M | 14.19M | 16.78M |
| Capital Lease Obligations | 0 | 151K | 104K | 164K | 350K | 0 | 1.22M | 0 | 2.01M | 0 | 2.76M | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 9.01M | 9.67M | 8.57M | 7.78M | 5.03M | 5.4M | 7.09M | 1.27M |
| Other Non-Current Liabilities | 33.99M | 40.27M | 44.13M | 57.9M | 39.07M | 52.55M | 55.74M | 61.9M | 36.23M | 42.55M | 49.25M | 4.42M |
| Total Liabilities | 84.39M | 87.79M | 102.22M | 122.7M | 123.29M | 141.19M | 153.71M | 164.1M | 160.06M | 132.66M | 151.45M | 125.3M |
| Total Debt | 22.56M | 27.03M | 31M | 35.5M | 39.89M | 40.66M | 42.25M | 43.37M | 44.25M | 16.5M | 19.09M | 18.82M |
| Net Debt | -5.52M | -26.68M | -35.4M | -34.49M | -30.71M | -30.76M | -41.97M | -59.58M | -59.51M | -87.48M | -117.7M | -112.73M |
| Debt / Equity | - | 5.25x | 3.51x | 1.23x | 0.77x | 0.70x | 0.78x | 0.37x | 0.41x | 0.12x | 0.12x | 0.09x |
| Debt / EBITDA | - | - | - | - | - | - | - | 6.98x | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | -9.58x | - | - | - | - |
| Interest Coverage | -10.93x | - | -664.47x | -43.86x | -4.06x | -8.68x | -132.54x | - | - | - | - | - |
| Total Equity | -21.69M | 5.14M | 8.83M | 28.8M | 51.9M | 57.86M | 54.15M | 116.33M | 107.44M | 133.56M | 155.97M | 207.76M |
| Equity Growth % | -345.58% | -82.14% | -82.98% | -50.23% | -4.15% | -50.26% | -49.6% | -12.9% | -31.12% | -35.72% | -28.26% | 14.62% |
| Book Value per Share | -0.24 | 0.06 | 0.11 | 0.36 | 0.64 | 0.69 | 0.68 | 1.42 | 1.35 | 1.69 | 1.98 | 2.63 |
| Total Shareholders' Equity | -21.69M | 5.14M | 8.83M | 28.8M | 51.9M | 57.86M | 54.15M | 116.33M | 107.44M | 133.56M | 155.97M | 207.76M |
| Common Stock | 4.69M | 4.61M | 4.19M | 4.05M | 4.04M | 4.03M | 4.01M | 3.99M | 3.98M | 3.95M | 3.95M | 3.95M |
| Retained Earnings | -435.36M | -407.71M | -386.36M | -361.66M | -336.89M | -328.6M | -330.32M | -265.94M | -272.21M | -244.15M | -220.46M | -166.05M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 1.19M | 27K | 355K | 495K | 1.06M | 819K | 284K | 456K | 715K | 355K | -568K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |